Cargando…

NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy

BACKGROUND: Diabetic nephropathy (DN) is one of the main complications of diabetes, and oxidative stress plays an important role in its progression. NAD(P)H: quinone oxidoreductase 1 (NQO1) protects cells from oxidative stress and toxic quinone damage. In the present study, we aimed to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Duojun, Song, Shan, Wang, Yuhan, Bian, Yawei, Wu, Ming, Wu, Haijiang, Shi, Yonghong, Duan, Huijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796493/ https://www.ncbi.nlm.nih.gov/pubmed/35090502 http://dx.doi.org/10.1186/s12967-021-03197-3

Ejemplares similares

The potential roles of NAD(P)H:quinone oxidoreductase 1 in the development of diabetic nephropathy and actin polymerization
por: Moon, Sung-Je, et al.
Publicado: (2020)

NAD(P)H: Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 Polymorphisms in Papillary Thyroid Microcarcinoma: Correlation with Phenotype
por: Lee, Junguee, et al.
Publicado: (2013)

Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases
por: Lee, Wang-Soo, et al.
Publicado: (2021)

Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 Polymorphism
por: Glorieux, Christophe, et al.
Publicado: (2019)

Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations
por: den Braver-Sewradj, Shalenie P., et al.
Publicado: (2017)

Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family
por: Vasiliou, Vasilis, et al.
Publicado: (2006)

Riboflavin compounds show NAD(P)H dependent quinone oxidoreductase-like quinone reducing activity
por: Nagase, Midori, et al.
Publicado: (2023)

Identification of NAD(P)H Quinone Oxidoreductase Activity in Azoreductases from P. aeruginosa: Azoreductases and NAD(P)H Quinone Oxidoreductases Belong to the Same FMN-Dependent Superfamily of Enzymes
por: Ryan, Ali, et al.
Publicado: (2014)

NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives
por: Ghorab, Mostafa M, et al.
Publicado: (2016)

Is NAD(P)H quinone oxidoreductase 1 a tumor promoter or suppressor in gastric cancer?
por: Cao, Lei, et al.
Publicado: (2023)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Localizes to the Mitotic Spindle in Human Cells
por: Siegel, David, et al.
Publicado: (2012)

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
por: Traver, R. D., et al.
Publicado: (1997)

Structural Insights into the NAD(P)H:Quinone Oxidoreductase from Phytophthora capsici
por: Yang, Cancan, et al.
Publicado: (2022)

Effects of transforming growth factor beta-activated kinase 1 (TAK1) on apoptosis of HK-2 cells in the high glucose environment
por: Wang, Yuhan, et al.
Publicado: (2022)

Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents
por: Zeekpudsa, Ponsilp, et al.
Publicado: (2014)

Aerobic Cytotoxicity of Aromatic N-Oxides: The Role of NAD(P)H:Quinone Oxidoreductase (NQO1)
por: Nemeikaitė-Čėnienė, Aušra, et al.
Publicado: (2020)

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) P187S Polymorphism and Prostate Cancer Risk in Caucasians
por: Stoehr, Christine G., et al.
Publicado: (2012)

Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signaling
por: Thapa, Dinesh, et al.
Publicado: (2020)

Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines
por: Patiño-Morales, Carlos César, et al.
Publicado: (2019)

NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
por: Joseph, P., et al.
Publicado: (1998)

Arylamino-nor-β-lapachone derivative-induced apoptosis in human prostate cancer cells: involvement of NAD(P)H:quinone oxidoreductase (NQO1)
por: Cavalcanti, Bruno C, et al.
Publicado: (2013)

CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner
por: Ren, Yunzhuo, et al.
Publicado: (2015)

NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG
por: Kasai, Shuya, et al.
Publicado: (2016)

NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places
por: Pey, Angel L., et al.
Publicado: (2019)

Biphasic Kinetic Behavior of E. coli WrbA, an FMN-Dependent NAD(P)H:Quinone Oxidoreductase
por: Kishko, Iryna, et al.
Publicado: (2012)

Metabolism and Tissue Distribution of Chelerythrine and Effects of Macleaya Cordata Extracts on Liver NAD(P)H Quinone Oxidoreductase
por: Huang, Chong-Yin, et al.
Publicado: (2021)

Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels
por: Nishida-Tamehiro, Kyoko, et al.
Publicado: (2022)

Structural basis of the pleiotropic and specific phenotypic consequences of missense mutations in the multifunctional NAD(P)H:quinone oxidoreductase 1 and their pharmacological rescue
por: Pacheco-Garcia, Juan Luis, et al.
Publicado: (2021)

NAD(P)H Quinone Oxidoreductase-1 Expression Promotes Self-Renewal and Therapeutic Resistance in Non-Small Cell Lung Cancer
por: Madajewski, Brian, et al.
Publicado: (2023)

Quinone binding site in a type VI sulfide:quinone oxidoreductase
por: Miklovics, Nikolett, et al.
Publicado: (2022)

Methylmercury (MeHg) transcriptionally regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) in Hepa-1c1c7 cells
por: Alqahtani, Mohammed A., et al.
Publicado: (2023)

Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H: quinone oxidoreductase 1 (NQO1)
por: Lienhart, Wolf-Dieter, et al.
Publicado: (2017)

FAD-deficient P187S mutation of NAD(P)H:quinone oxidoreductase 1 (NQO1*2) binds and accelerates β-amyloid aggregation
por: Panja, Sudipta, et al.
Publicado: (2022)

Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase
por: Lienhart, Wolf-Dieter, et al.
Publicado: (2014)

NAD(P)H: Quinone Oxidoreductase 1 Deficiency Conjoint with Marginal Vitamin C Deficiency Causes Cigarette Smoke Induced Myelodysplastic Syndromes
por: Das, Archita, et al.
Publicado: (2011)

A small molecule chaperone rescues the stability and activity of a cancer‐associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro
por: Strandback, Emilia, et al.
Publicado: (2019)

NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1
por: Lin, Li-Ching, et al.
Publicado: (2020)

A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells
por: Zhu, Ya, et al.
Publicado: (2019)

Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells
por: Roubalová, Lenka, et al.
Publicado: (2017)

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.
por: Kelsey, K. T., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_ugmvtomc3qr1vtl5t1r3jk17pi